Full citation: H. Wilton-Clark, M.N.A. Shah, J. Leckie, S. Hernandez Rodriguez, A. Al-Aghbari, P. Zhabyeyev, R. Maruyama, Y. Aoki, G.Y. Oudit, & T. Yokota, DMD-Null mice exhibit severe muscle weakness, impaired regeneration, and deficient satellite cell function, Proc. Natl. Acad. Sci. U.S.A. 123 (25) e2606703123, https://doi.org/10.1073/pnas.2606703123 (2026).
Thanks to grant funding from Defeat Duchenne Canada, Dr. Yokota and his research team have achieved a significant milestone in Duchenne muscular dystrophy (DMD) research.
Key Findings:
Their team studied the DMD-Null mouse model (which produces no dystrophin at all) and compared it to the widely used mdx model (which still produces trace amounts of the protein). Their findings revealed:
- Increased Severity: The DMD-Null model exhibited more pronounced muscle weakness and lower exercise endurance.
- Impaired Recovery: These mice showed a significantly reduced ability to repair damaged muscle tissue.
- Stem Cell Dysfunction: Muscle stem cells, which are crucial for muscle growth and self-repair, did not function as effectively in the DMD-Null model.
Why This Matters:
These insights suggest that even very small or short forms of dystrophin play a critical role in maintaining muscle health and aiding recovery. This research provides a vital new model for testing future therapies and highlights the importance of targeting muscle repair and regeneration alongside restoring dystrophin.
We extend our deepest gratitude to Dr. Yokota and his team for their dedication to bringing us closer to better treatments for individuals and families impacted by Duchenne.
To read more about this research, you can access the study abstract through the link above.
Defeat Duchenne Canada will break down recent medical journal publications to keep our Duchenne community up to date on the rapidly changing Duchenne landscape. Have a question or comment related to the publication? Contact us at [email protected].
Want to know more about Duchenne Research?
Scientists and medical experts have been tirelessly pursuing diverse approaches to defeat Duchenne muscular dystrophy. From tackling the root cause to alleviating symptoms, the field of research is vast and promising. Explore the various strategies being developed and tested, and gain insights into the future of muscular dystrophy treatment: